Chemokine receptor oligomerization and allostery.

[1]  R. Leurs,et al.  Identification and profiling of CXCR3–CXCR4 chemokine receptor heteromer complexes , 2013, British journal of pharmacology.

[2]  R. Leurs,et al.  Inhibition of CXCR3‐mediated chemotaxis by the human chemokine receptor‐like protein CCX‐CKR , 2013, British journal of pharmacology.

[3]  J. Sodroski,et al.  A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry. , 2012, Biochemistry.

[4]  A. Baíllo,et al.  EBI2 regulates CXCL13‐mediated responses by heterodimerization with CXCR5 , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  D. Rodríguez,et al.  Characterization of the homodimerization interface and functional hotspots of the CXCR4 chemokine receptor , 2012, Proteins.

[6]  A. Mantovani,et al.  The biochemistry and biology of the atypical chemokine receptors. , 2012, Immunology letters.

[7]  C. Martínez-A,et al.  Chemokine receptor oligomerization: a further step toward chemokine function. , 2012, Immunology letters.

[8]  G. Dellaire,et al.  Dopamine Receptor-Interacting Protein 78 Acts as a Molecular Chaperone for CCR5 Chemokine Receptor Signaling Complex Organization , 2012, PloS one.

[9]  J. Kigawa,et al.  Regulation of Cell Migration by Sphingomyelin Synthases: Sphingomyelin in Lipid Rafts Decreases Responsiveness to Signaling by the CXCL12/CXCR4 Pathway , 2012, Molecular and Cellular Biology.

[10]  Kendra M. Haney,et al.  Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5. , 2012, Organic & biomolecular chemistry.

[11]  R. Kraft,et al.  The presumed atypical chemokine receptor CXCR7 signals through Gi/o proteins in primary rodent astrocytes and human glioma cells , 2012, Glia.

[12]  S. Takayama,et al.  Secreted CXCL12 (SDF-1) forms dimers under physiological conditions. , 2012, The Biochemical journal.

[13]  R. Leurs,et al.  Pharmacological modulation of chemokine receptor function , 2012, British journal of pharmacology.

[14]  C. White,et al.  Identification and Profiling of Novel α1A-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer , 2012, The Journal of Biological Chemistry.

[15]  Dafydd G. Thomas,et al.  Scavenging of CXCL12 by CXCR7 Promotes Tumor Growth and Metastasis of CXCR4-positive Breast Cancer Cells , 2011, Oncogene.

[16]  D. Dupré,et al.  Dependence on different Rab GTPases for the trafficking of CXCR4 and CCR5 homo or heterodimers between the endoplasmic reticulum and plasma membrane in Jurkat cells. , 2011, Cellular signalling.

[17]  N. Heveker,et al.  Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways , 2011, Proceedings of the National Academy of Sciences.

[18]  Laura Martínez Muñoz,et al.  Receptor oligomerization: a pivotal mechanism for regulating chemokine function. , 2011, Pharmacology & therapeutics.

[19]  J. Prestegard,et al.  Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data. , 2011, Structure.

[20]  Laura M Lechuga,et al.  Technical Advance: Surface plasmon resonance‐based analysis of CXCL12 binding using immobilized lentiviral particles , 2011, Journal of leukocyte biology.

[21]  T. Sakmar,et al.  CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration* , 2011, The Journal of Biological Chemistry.

[22]  T. Schall,et al.  The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells , 2011, Molecular Cancer.

[23]  T. Schall,et al.  Overcoming hurdles in developing successful drugs targeting chemokine receptors , 2011, Nature Reviews Immunology.

[24]  R. Leurs,et al.  G protein‐coupled receptors: walking hand‐in‐hand, talking hand‐in‐hand? , 2011, British journal of pharmacology.

[25]  T. Handel,et al.  Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. , 2011, Experimental cell research.

[26]  N. Heveker,et al.  Different Effects of the Different Natural CC Chemokine Receptor 2b Ligands on β-Arrestin Recruitment, Gαi Signaling, and Receptor Internalization , 2011, Molecular Pharmacology.

[27]  K. Eidne,et al.  Application of G protein-coupled receptor-heteromer identification technology to monitor β-arrestin recruitment to G protein-coupled receptor heteromers. , 2011, Assay and drug development technologies.

[28]  H. Vischer,et al.  Herpesvirus-encoded GPCRs rewire cellular signaling , 2011, Molecular and Cellular Endocrinology.

[29]  Eric Trinquet,et al.  A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  T. Handel,et al.  A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis , 2010, Molecular Cancer.

[31]  R. Koenen,et al.  Polymerization of MIP‐1 chemokine (CCL3 and CCL4) and clearance of MIP‐1 by insulin‐degrading enzyme , 2010, The EMBO journal.

[32]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[33]  N. Birdsall.  Class A GPCR heterodimers: evidence from binding studies. , 2010, Trends in pharmacological sciences.

[34]  T. Narumi,et al.  Bivalent ligands of CXCR4 with rigid linkers for elucidation of the dimerization state in cells. , 2010, Journal of the American Chemical Society.

[35]  S. Sligar,et al.  Monomeric Rhodopsin Is Sufficient for Normal Rhodopsin Kinase (GRK1) Phosphorylation and Arrestin-1 Binding* , 2010, The Journal of Biological Chemistry.

[36]  J. Sodroski,et al.  Thermal Stability of the Human Immunodeficiency Virus Type 1 (HIV-1) Receptors, CD4 and CXCR4, Reconstituted in Proteoliposomes , 2010, PloS one.

[37]  D. Dupré,et al.  Na+/H+ Exchanger Regulatory Factor-1 Is Involved in Chemokine Receptor Homodimer CCR5 Internalization and Signal Transduction but Does Not Affect CXCR4 Homodimer or CXCR4-CCR5 Heterodimer* , 2010, The Journal of Biological Chemistry.

[38]  R. Leurs,et al.  The Epstein-Barr Virus-encoded G Protein-coupled Receptor BILF1 Hetero-oligomerizes with Human CXCR4, Scavenges Gαi Proteins, and Constitutively Impairs CXCR4 Functioning* , 2010, The Journal of Biological Chemistry.

[39]  M. Schwarz,et al.  Anti-chemokine small molecule drugs: a promising future? , 2010, Expert opinion on investigational drugs.

[40]  Gregory I. Mashanov,et al.  Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules , 2010, Proceedings of the National Academy of Sciences.

[41]  R. Franco,et al.  Dynamic Regulation of CXCR1 and CXCR2 Homo- and Heterodimers1 , 2009, The Journal of Immunology.

[42]  Hideo Takahashi,et al.  Structural Basis of the Interaction between Chemokine Stromal Cell-derived Factor-1/CXCL12 and Its G-protein-coupled Receptor CXCR4* , 2009, The Journal of Biological Chemistry.

[43]  Adam J Kuszak,et al.  Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. , 2009, The Journal of biological chemistry.

[44]  M. Parmentier,et al.  Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists* , 2009, The Journal of Biological Chemistry.

[45]  Graeme Milligan,et al.  G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function , 2009, British journal of pharmacology.

[46]  T. Schall,et al.  Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands , 2009, The Journal of Immunology.

[47]  F. Baleux,et al.  CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. , 2009, Blood.

[48]  N. Heveker,et al.  AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties , 2009, Molecular Pharmacology.

[49]  Bruno Antonny,et al.  The apparent cooperativity of some GPCRs does not necessarily imply dimerization. , 2009, Trends in pharmacological sciences.

[50]  Mudit Gupta,et al.  Imaging chemokine receptor dimerization with firefly luciferase complementation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  G. Graham.  D6 and the atypical chemokine receptor family: Novel regulators of immune and inflammatory processes , 2009, European journal of immunology.

[52]  N. Yamamoto,et al.  Ligand‐independent higher‐order multimerization of CXCR4, a G‐protein‐coupled chemokine receptor involved in targeted metastasis , 2009, Cancer science.

[53]  A. Schreiber,et al.  Pharmacological and biochemical characterization of human cytomegalovirus-encoded G protein-coupled receptors. , 2009, Methods in enzymology.

[54]  Saskia Nijmeijer,et al.  Viral hijacking of human receptors through heterodimerization. , 2008, Biochemical and biophysical research communications.

[55]  R. Offord,et al.  Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide , 2008, Proceedings of the National Academy of Sciences.

[56]  T. Jin,et al.  Fluorescence Resonance Energy Transfer Imaging Reveals that Chemokine-Binding Modulates Heterodimers of CXCR4 and CCR5 Receptors , 2008, PloS one.

[57]  Christoph Seibert,et al.  Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12 , 2008, Science Signaling.

[58]  F. Eusebi,et al.  Chemokine CXCL8 modulates GluR1 phosphorylation , 2008, Journal of Neuroimmunology.

[59]  Tullio Pozzan,et al.  CXCR4–CCR5: A couple modulating T cell functions , 2008, Proceedings of the National Academy of Sciences.

[60]  F. Baleux,et al.  CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. , 2008, Blood.

[61]  D. Greaves,et al.  The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization , 2008, Molecular Pharmacology.

[62]  G. Milligan,et al.  CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer , 2008, The Biochemical journal.

[63]  Krzysztof Palczewski,et al.  Efficient Coupling of Transducin to Monomeric Rhodopsin in a Phospholipid Bilayer* , 2008, Journal of Biological Chemistry.

[64]  Mario Mellado,et al.  Ligand stabilization of CXCR4/δ‐opioid receptor heterodimers reveals a mechanism for immune response regulation , 2008, European journal of immunology.

[65]  Marc Parmentier,et al.  Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers* , 2007, Journal of Biological Chemistry.

[66]  Richard P. Harvey,et al.  Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 , 2007, Proceedings of the National Academy of Sciences.

[67]  T. Chun,et al.  Structural and functional characterization of CC chemokine CCL14. , 2007, Biochemistry.

[68]  S. O’Brien,et al.  Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes: a potential mechanism for receptor dimerization. , 2007, Genomics.

[69]  Richard N. Zare,et al.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.

[70]  Graeme Milligan,et al.  The specificity and molecular basis of α1-adrenoceptor and CXCR chemokine receptor dimerization , 2007, Journal of Molecular Neuroscience.

[71]  A. Rot,et al.  Throwing light on DARC. , 2006, Biochemical Society transactions.

[72]  C. Combs,et al.  Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions , 2006, Molecular Cancer Therapeutics.

[73]  Ashok Kumar,et al.  CXCR4 physically associates with the T cell receptor to signal in T cells. , 2006, Immunity.

[74]  M. Parmentier,et al.  Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers , 2006, Molecular Pharmacology.

[75]  F. Hamdan,et al.  Monitoring Protein‐Protein Interactions in Living Cells by Bioluminescence Resonance Energy Transfer (BRET) , 2006, Current protocols in neuroscience.

[76]  M. Oppermann,et al.  G Protein-coupled Receptor Kinases Promote Phosphorylation and β-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers* , 2005, Journal of Biological Chemistry.

[77]  Graeme Milligan,et al.  The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities* , 2005, Journal of Biological Chemistry.

[78]  J. Esko,et al.  Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses , 2005, Nature Immunology.

[79]  F. Eusebi,et al.  Cysteine residues are critical for chemokine receptor CXCR2 functional properties. , 2005, Experimental cell research.

[80]  S. Marullo,et al.  On the dimerization of CCR5 , 2005, Nature Immunology.

[81]  Antonio Lanzavecchia,et al.  T cell costimulation by chemokine receptors , 2005, Nature Immunology.

[82]  Michel Bouvier,et al.  Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.

[83]  M. Parmentier,et al.  Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.

[84]  M. Norcross,et al.  Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4 , 2004, Journal of cellular biochemistry.

[85]  P. Toth,et al.  Regulation of CXCR4 Receptor Dimerization by the Chemokine SDF-1α and the HIV-1 Coat Protein gp120: A Fluorescence Resonance Energy Transfer (FRET) Study , 2004, Journal of Pharmacology and Experimental Therapeutics.

[86]  T. Kohout,et al.  Differential Desensitization, Receptor Phosphorylation, β-Arrestin Recruitment, and ERK1/2 Activation by the Two Endogenous Ligands for the CC Chemokine Receptor 7* , 2004, Journal of Biological Chemistry.

[87]  T. Handel,et al.  Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1 , 2004, Journal of Biological Chemistry.

[88]  C. Martínez-A,et al.  Blocking HIV‐1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor , 2004, The EMBO journal.

[89]  Chongguang Chen,et al.  Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. , 2004, European journal of pharmacology.

[90]  Alfonso Valencia,et al.  Identification of amino acid residues crucial for chemokine receptor dimerization , 2004, Nature Immunology.

[91]  T. Handel,et al.  Chemokine structure and receptor interactions. , 2004, Ernst Schering Research Foundation workshop.

[92]  Cristina Limatola,et al.  Ligand-independent CXCR2 Dimerization* , 2003, Journal of Biological Chemistry.

[93]  C. Weber,et al.  Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. , 2003, Blood.

[94]  Marc Parmentier,et al.  The Core Domain of Chemokines Binds CCR5 Extracellular Domains while Their Amino Terminus Interacts with the Transmembrane Helix Bundle* , 2003, The Journal of Biological Chemistry.

[95]  Timothy N. C. Wells,et al.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[96]  Gregory J Babcock,et al.  Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor* , 2003, The Journal of Biological Chemistry.

[97]  R. Doi,et al.  Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. , 2002, Experimental cell research.

[98]  M. Alizon,et al.  Rescue of HIV-1 Receptor Function through Cooperation between Different Forms of the CCR5 Chemokine Receptor* , 2002, The Journal of Biological Chemistry.

[99]  Michel Bouvier,et al.  Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.

[100]  Marc Parmentier,et al.  Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. , 2002, Molecular biology of the cell.

[101]  M. Alizon,et al.  Determinants of the trans-Dominant Negative Effect of Truncated Forms of the CCR5 Chemokine Receptor* , 2001, The Journal of Biological Chemistry.

[102]  Georgios G. Gkoutos,et al.  Lipid-facing correlated mutations and dimerization in G-protein coupled receptors. , 2001, Protein engineering.

[103]  Mario Mellado,et al.  Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.

[104]  L. Mitnaul,et al.  CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T Cells , 2001, Journal of Virology.

[105]  S. Glaser,et al.  Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. , 2000, Critical reviews in oncology/hematology.

[106]  J. Wang,et al.  Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response. , 2000, Immunopharmacology.

[107]  C. Martínez-A,et al.  HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[108]  K. Jarnagin,et al.  Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. , 1999, Biochemistry.

[109]  N. Tarasova,et al.  Inhibition of G-protein-coupled Receptor Function by Disruption of Transmembrane Domain Interactions* , 1999, The Journal of Biological Chemistry.

[110]  C. Hogaboam,et al.  Chemokines and asthma: redundancy of function or a coordinated effort? , 1999, The Journal of clinical investigation.

[111]  C. Martínez-A,et al.  Chemokine control of HIV-1 infection , 1999, Nature.

[112]  Q. Sattentau,et al.  Constitutive cell surface association between CD4 and CCR5. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[113]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[114]  A. Richmond,et al.  Multiple chemotactic factors: fine control or redundancy? , 1999, Trends in pharmacological sciences.

[115]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[116]  F. Sánchez‐Madrid,et al.  Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis , 1999, The Journal of cell biology.

[117]  Alan Wise,et al.  Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.

[118]  M. Mack,et al.  Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.

[119]  B. Borowsky,et al.  GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. , 1998, Nature.

[120]  Kuan-Teh Jeang,et al.  Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.

[121]  B. Sykes,et al.  Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.

[122]  C. Power,et al.  Glycosaminoglycans mediate cell surface oligomerization of chemokines. , 1997, Biochemistry.

[123]  M. Montjovent,et al.  Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.

[124]  B. Rollins,et al.  A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer , 1995, Molecular and cellular biology.

[125]  B. Sykes,et al.  Structure‐activity relationships of chemokines , 1995, Journal of leukocyte biology.

[126]  B. Sykes,et al.  Neutrophil activation by monomeric interleukin-8. , 1994, Science.

[127]  H. Flad,et al.  Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. , 1991, Cytokine.